Menu

Top Stories

Published on Wednesday, April 20, 2016

Kevin Shroyer, father of Alpha lung donor, completes Boston Marathon

Kevin Shroyer, father of Alpha lung donor, completes Boston Marathon

Kevin Shroyer, the father of a 14-year-old girl whose donated lungs saved an Alpha’s life, completed the Boston Marathon on Monday, April 18 in her honor.

Kevin Shroyer

Although the experienced distance runner was happy to cross the finish line, he said he would like to post a faster time next year. He qualified for the event by completing a previous marathon in three hours and 35 minutes, but finished on Monday in 4:01.

"Since it was not what I was expecting to run, I will let everyone know what happened,” he wrote Monday on his Facebook page. “I was pretty much right on my pace upon climbing the infamous Heartbreak Hill. However, upon descending the back side, my right quad seized up suddenly, forcing me to come to a dead stop and grab onto a handrail to keep from falling.

“Fortunately, I was running close to the side of the road at the time. A sweet older woman spectator immediately saw the distress I was in as I could not straighten that leg out below the knee. She held onto me until the pain subsided and I was able to gradually massage it until it released, but my day was effectively over at that point.”

Calling it a “frustrating and humbling” experience, Shroyer struggled over the last six miles, alternating between fast walking and very slow running.

“This was something that had NEVER happened to me before in a race,” he wrote. “However, I accomplished goal #1 and that was to qualify, run, and finish the race for Korinne and to promote organ, tissue and eye donation on the biggest running stage in the world! It wasn't my plan to be out there for 4:01, but perhaps it was God's plan.

“Timewise, this was my worst marathon in years. But, maybe by me being out there all those additional minutes, someone was impacted by seeing Korinne's picture on the back of my singlet and the fact that she was an organ and tissue donor. Indeed, I had a number of other runners, male and female, offer expressions of condolence to me throughout the day, which was nice. So, if that is the one positive takeaway from today's experience, then I can accept that and would do it all over again!”

Shroyer has already qualified for the 2017 Boston Marathon, and he plans to run it.

“After looking at today's result they might not want me back, but too bad, I am coming!” he said. “Today will not be my defining Boston moment!"

To read about how Shroyer prepared for the Boston Marathon, click here.


Print

The Celtic Connection 2019: The pot of gold at the end of the rainbow

Sunday, March 17, 2019
The 2019 Celtic Connection, an annual Building Friends for a Cure event held in Boston, Massachusetts, joined 385 guests for a great night to raise awareness and over $138,000 for Alpha-1 Antitrypsin Deficiency (Alpha-1) research and related...
Divider

FDA to host public meeting on: “Patient Perspectives on the Impact of Rare Diseases,” in April

Wednesday, March 6, 2019
The U.S. Food and Drug Administration (FDA) announced a public meeting and an opportunity for public comment on “Patient Perspectives on the Impact of Rare Diseases: Bridging the Commonalities,” on April 29th, 2019. This public...
Divider

The energy from Rare Disease Day continues

Tuesday, March 5, 2019
On February 28th, 2019, the Alpha-1 Foundation proudly wore its stripes to support the National Institutes of Health (NIH) sponsored Rare Disease Day (RDD) along with patient organizations, politicians, caregivers, medical professionals,...
Divider

Florida couple raising awareness for rare disease

Wednesday, February 27, 2019
Walking from his front door to the driveway’s end can leave Doug Peters gasping for air. Four years ago, he was diagnosed with Alpha-1 Antitrypsin Deficiency (Alpha-1). “It was a tough reality when they explained to us why he has...
Divider

The Alpha-1 Foundation gears up for the 2019 Global meetings in Dubrovnik, Croatia

Tuesday, February 26, 2019
MIAMI, Feb. 26th, 2019 - The 7th Alpha-1 Global Patient Congress and 4th International Research Conference on Alpha-1 Antitrypsin will be held April 3-6, at the Sheraton Dubrovnik Riviera Hotel in Dubrovnik, Croatia. Patient leaders, physicians...
Divider

The Johnsons are ready to party for a cure… ‘80s style!

Friday, February 15, 2019
Richard and Sarah Johnson of St. Johns, Florida, have not stop believing in the mission of the Alpha-1 Foundation. Eleven years ago, when their son Lucas and daughter Grace were diagnosed with Alpha-1 Antitrypsin Deficiency (Alpha-1) they made a...
Divider

Alpha-1 Foundation expresses gratitude to plasma donors

Wednesday, February 13, 2019
Recently, the New York Times published an article that, in the opinion of the Alpha-1 Foundation, portrayed an image of plasma donors that only focused on one side of the story.  Plasma donors can come from all backgrounds and levels of...
Divider

NORD continues to bridge the gap between patients and their health care

Thursday, February 7, 2019
Since its inception in the early 1980s, the National Organization for Rare Disorders (NORD) has been instrumental in providing assistance to individuals affected by rare diseases and their families; it was influential in the Orphan Drug Act of...
Divider

Alpha-1 Foundation welcomes new President and CEO

Monday, February 4, 2019
The Alpha-1 Foundation Board of Directors is excited to announce the appointment of Miriam O’Day as the new president and chief executive officer (CEO) of the Alpha-1 Foundation. “We thank Miriam for serving as interim CEO, since...
Divider

Tips and resources for Alphas and the cold weather

Wednesday, January 30, 2019
Cold weather conditions can worsen symptoms for lung affected Alphas and for patients with Chronic Obstructive Pulmonary Disease (COPD), as low temperatures can often lead to fatigue and windy days can cause shortness of breath. Also, the dry...
Divider

Alpha friend and leader Jim Quill passes away

Monday, January 14, 2019
It is with a heavy heart that the Alpha-1 Foundation shares the passing of a dear friend and leader, James Quill on Sunday, January 13th, 2019 in Bluffton, South Carolina. He was 67. Jim was on the Alpha-1 Foundation Board of Directors since...
Divider

Shire is now part of Takeda

Tuesday, January 8, 2019
Takeda Pharmaceutical Company Ltd. and Shire Biotechnology company took an exciting step forward by completing the acquisition that was announced in 2018 and becoming a global biopharmaceutical company headquartered in...
Divider
12345678910Last

Article Search

Enter keywords in text box and click Search button for results.

Archive